KINGDON CAPITAL MANAGEMENT, L.L.C. - Q4 2021 holdings

$870 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 77 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 91.9% .

 Value Shares↓ Weighting
QQQ NewINVESCO QQQ TRput$74,875,000188,200
+100.0%
8.61%
FB BuyMETA PLATFORMS INCcl a$51,665,000
+23.2%
153,605
+24.3%
5.94%
+16.4%
RAPT  RAPT THERAPEUTICS INC$42,178,000
+18.3%
1,148,3210.0%4.85%
+11.8%
BHVN SellBIOHAVEN PHARMACTL HLDG CO L$41,394,000
-18.4%
300,373
-17.8%
4.76%
-22.9%
RNR NewRENAISSANCERE HLDGS LTD$29,633,000175,000
+100.0%
3.41%
BHVN NewBIOHAVEN PHARMACTL HLDG CO Lcall$27,562,000200,000
+100.0%
3.17%
HUM BuyHUMANA INC$26,453,000
+101.1%
57,029
+68.7%
3.04%
+90.1%
APG SellAPI GROUP CORP$26,289,000
-5.2%
1,020,128
-25.1%
3.02%
-10.4%
TNDM BuyTANDEM DIABETES CARE INC$22,578,000
+70.4%
150,000
+35.1%
2.60%
+61.0%
BIIB NewBIOGEN INCcall$22,552,00094,000
+100.0%
2.59%
PANW NewPALO ALTO NETWORKS INC$21,658,00038,900
+100.0%
2.49%
AVY BuyAVERY DENNISON CORP$21,191,000
+28.4%
97,847
+22.8%
2.44%
+21.4%
AMZN BuyAMAZON COM INC$20,963,000
+40.8%
6,287
+38.8%
2.41%
+33.1%
IWM SellISHARES TRput$19,353,000
-79.7%
87,000
-80.0%
2.22%
-80.8%
ACGL NewARCH CAP GROUP LTDord$17,780,000400,000
+100.0%
2.04%
SBNY SellSIGNATURE BK NEW YORK N Y$17,488,000
+15.2%
54,065
-3.0%
2.01%
+8.9%
VRTX NewVERTEX PHARMACEUTICALS INC$16,975,00077,300
+100.0%
1.95%
URI NewUNITED RENTALS INC$14,992,00045,117
+100.0%
1.72%
DHR NewDANAHER CORPORATION$14,973,00045,509
+100.0%
1.72%
UAA SellUNDER ARMOUR INCcl a$14,769,000
-26.8%
697,000
-30.3%
1.70%
-30.8%
ABBV NewABBVIE INC$13,432,00099,200
+100.0%
1.54%
NewMIRION TECHNOLOGIES INC$12,967,0001,238,500
+100.0%
1.49%
MRNA NewMODERNA INCput$12,699,00050,000
+100.0%
1.46%
BLMN NewBLOOMIN BRANDS INC$12,273,000585,000
+100.0%
1.41%
APO NewAPOLLO GLOBAL MGMT INC$11,227,000155,000
+100.0%
1.29%
ENTA NewENANTA PHARMACEUTICALS INCput$11,217,000150,000
+100.0%
1.29%
JCI NewJOHNSON CTLS INTL PLC$10,782,000132,600
+100.0%
1.24%
CARA BuyCARA THERAPEUTICS INC$10,755,000
-2.7%
883,000
+23.4%
1.24%
-8.0%
HAE NewHAEMONETICS CORP MASScall$10,608,000200,000
+100.0%
1.22%
WSC SellWILLSCOT MOBIL MINI HLDNG CO$10,477,000
-14.4%
256,529
-33.5%
1.20%
-19.0%
TECK SellTECK RESOURCES LTDcl b$10,371,000
-31.7%
359,850
-41.0%
1.19%
-35.4%
Y NewALLEGHANY CORP MD$10,348,00015,500
+100.0%
1.19%
NewFLUENCE ENERGY INC$10,318,000290,145
+100.0%
1.19%
ARGX NewARGENX SEsponsored adr$9,766,00027,889
+100.0%
1.12%
MSFT SellMICROSOFT CORP$8,408,000
-17.4%
25,000
-30.8%
0.97%
-21.9%
PANW NewPALO ALTO NETWORKS INCput$8,184,00014,700
+100.0%
0.94%
PRAX  PRAXIS PRECISION MEDICINES I$8,165,000
+6.5%
414,4890.0%0.94%
+0.8%
GTYH  GTY TECHNOLOGY HOLDINGS INC$7,769,000
-10.9%
1,159,6000.0%0.89%
-15.8%
XAIR  BEYOND AIR INC$7,365,000
-15.1%
780,2280.0%0.85%
-19.8%
NAPA BuyDUCKHORN PORTFOLIO INC$7,354,000
+174.6%
315,083
+169.3%
0.85%
+159.5%
HAE BuyHAEMONETICS CORP MASS$7,160,000
+1.4%
135,000
+35.0%
0.82%
-4.2%
GS NewGOLDMAN SACHS GROUP INC$6,886,00018,000
+100.0%
0.79%
SellSOVOS BRANDS INC$6,226,000
-11.6%
413,672
-18.1%
0.72%
-16.5%
CRIS BuyCURIS INC$6,208,000
-38.0%
1,304,220
+2.0%
0.71%
-41.4%
SLGL  SOL GEL TECHNOLOGIES$6,163,000
-26.0%
832,8000.0%0.71%
-30.0%
DIS SellDISNEY WALT CO$5,808,000
-67.6%
37,500
-64.6%
0.67%
-69.3%
ARNA NewARENA PHARMACEUTICALS INC$5,163,00055,555
+100.0%
0.59%
EQH SellEQUITABLE HLDGS INC$4,919,000
-50.3%
150,000
-55.1%
0.57%
-53.0%
SCYX BuySCYNEXIS INC$4,862,000
+44.0%
797,048
+25.1%
0.56%
+36.0%
ACET BuyADICET BIO INC$4,810,000
+338.1%
275,000
+96.4%
0.55%
+312.7%
NewJASPER THERAPEUTICS INC$4,239,000540,000
+100.0%
0.49%
OSTK NewOVERSTOCK COM INC DELcall$4,131,00070,000
+100.0%
0.48%
 IMAGO BIOSCIENCES INC$4,122,000
+18.4%
173,8300.0%0.47%
+11.8%
MTEM  MOLECULAR TEMPLATES INC$4,004,000
-41.6%
1,021,3170.0%0.46%
-44.8%
VINC BuyVINCERX PHARMA INC$3,923,000
-20.4%
385,000
+26.3%
0.45%
-24.8%
RAPT NewRAPT THERAPEUTICS INCcall$3,673,000100,000
+100.0%
0.42%
NUVB NewNUVATION BIO INC$3,600,000423,500
+100.0%
0.41%
ANIP NewANI PHARMACEUTICALS INC$2,995,00065,000
+100.0%
0.34%
MSAC  MEDICUS SCIENCES ACQUISITION$2,916,000
-0.3%
300,0000.0%0.34%
-5.9%
TMQ  TRILOGY METALS INC NEW$2,761,000
-10.8%
1,673,4610.0%0.32%
-15.9%
GEG  GREAT ELM GROUP INC$2,631,000
-6.7%
1,259,0490.0%0.30%
-11.7%
WNS SellWNS HLDGS LTDspon adr$2,426,000
-25.9%
27,500
-31.2%
0.28%
-29.9%
XAIR NewBEYOND AIR INCcall$2,360,000250,000
+100.0%
0.27%
GNCA  GENOCEA BIOSCIENCES INC$2,288,000
-39.6%
1,972,0560.0%0.26%
-43.0%
RDUS NewRADIUS HEALTH INC$2,249,000325,000
+100.0%
0.26%
RXDX NewPROMETHEUS BIOSCIENCES INC$2,030,00051,332
+100.0%
0.23%
EUCR  EUCRATES BIOMEDICAL ACQU COR$1,952,000
-0.2%
200,0000.0%0.22%
-5.9%
BBIO NewBRIDGEBIO PHARMA INCcall$1,668,000100,000
+100.0%
0.19%
IFRX SellINFLARX NV$1,547,000
+49.3%
325,000
-18.8%
0.18%
+41.3%
DCPH NewDECIPHERA PHARMACEUTICALS INcall$1,466,000150,000
+100.0%
0.17%
NewENVVENO MEDICAL CORPORATION$1,444,000219,180
+100.0%
0.17%
FHTX SellFOGHORN THERAPEUTICS INC$1,243,000
-56.6%
54,341
-73.6%
0.14%
-59.0%
RDUS NewRADIUS HEALTH INCcall$1,085,000156,800
+100.0%
0.12%
NEXI  NEXIMMUNE INC$544,000
-69.5%
117,9620.0%0.06%
-71.0%
NewBAKKT HOLDINGS INCcall$255,00030,000
+100.0%
0.03%
EUCRW  EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202$36,000
-25.0%
66,6650.0%0.00%
-33.3%
MSACW  MEDICUS SCIENCES ACQUISITION*w exp 02/12/202$22,0000.0%33,3320.0%0.00%0.0%
XCUR ExitEXICURE INC$0-339,395
-100.0%
-0.05%
ExitGINKGO BIOWORKS HOLDINGS INC$0-75,000
-100.0%
-0.11%
APLS ExitAPELLIS PHARMACEUTICALS INCput$0-50,000
-100.0%
-0.20%
FVRR ExitFIVERR INTL LTDput$0-10,000
-100.0%
-0.22%
PAGS ExitPAGSEGURO DIGITAL LTDput$0-47,800
-100.0%
-0.30%
APLS ExitAPELLIS PHARMACEUTICALS INC$0-100,000
-100.0%
-0.40%
EDIT ExitEDITAS MEDICINE INCput$0-100,000
-100.0%
-0.50%
GSAH ExitGS ACQUISITION HLDGS CORP II$0-658,000
-100.0%
-0.82%
HAE ExitHAEMONETICS CORP MASSput$0-100,000
-100.0%
-0.86%
FIS ExitFIDELITY NATL INFORMATION SV$0-65,650
-100.0%
-0.97%
ROP ExitROPER TECHNOLOGIES INC$0-20,650
-100.0%
-1.12%
SE ExitSEA LTDsponsord ads$0-31,000
-100.0%
-1.20%
TWLO ExitTWILIO INCcl a$0-33,334
-100.0%
-1.29%
ATH ExitATHENE HOLDING LTDcl a$0-166,825
-100.0%
-1.40%
GNRC ExitGENERAC HLDGS INC$0-30,000
-100.0%
-1.49%
PAGS ExitPAGSEGURO DIGITAL LTD$0-243,450
-100.0%
-1.53%
ADS ExitALLIANCE DATA SYSTEMS CORP$0-130,000
-100.0%
-1.60%
FOUR ExitSHIFT4 PMTS INCcl a$0-232,370
-100.0%
-2.19%
XBI ExitSPDR SER TRput$0-185,000
-100.0%
-2.83%
LAD ExitLITHIA MTRS INC$0-78,408
-100.0%
-3.02%
SPY ExitSPDR S&P 500 ETF TRput$0-270,000
-100.0%
-14.10%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
FLEXION THERAPEUTICS INC30Q2 20213.1%
SPDR S&P 500 ETF TR29Q3 202334.8%
ISHARES TR27Q3 202313.2%
HERON THERAPEUTICS INC23Q3 20194.2%
SOL GEL TECHNOLOGIES23Q3 20231.5%
META PLATFORMS INC22Q3 20235.9%
LIBERTY MEDIA CORP21Q4 20181.4%
NOMAD HLDGS LTD19Q3 20202.1%
AMAZON COM INC18Q3 20227.6%
SPDR SER TR18Q3 20235.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.

Latest significant ownerships (13-D/G)
KINGDON CAPITAL MANAGEMENT, L.L.C. Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Praxis Precision Medicines, Inc.January 25, 20232,855,9896.1%
GTY Technology Holdings Inc.February 10, 20201,598,2123.1%
Jaguar Health, Inc.February 10, 20202700.0%
Sesen Bio, Inc.February 10, 20204,040,8353.9%
Eleven Biotherapeutics, Inc.April 04, 20182,213,9805.1%
AIT Therapeutics, Inc.April 02, 2018400,8594.8%
FATE THERAPEUTICS INCSold outFebruary 14, 201800.0%
Great Elm Capital Group, Inc.February 14, 20181,267,0305.0%
HERON THERAPEUTICS, INC. /DE/February 14, 20182,179,6203.4%
Horizon Pharma plcSold outFebruary 14, 201800.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-04-15
13F-HR/A2024-03-18
13F-HR2024-02-14
SC 13G/A2024-02-06
SC 13G/A2024-02-06
SC 13G/A2023-11-29
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G2023-04-13

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.

Compare quarters

Export KINGDON CAPITAL MANAGEMENT, L.L.C.'s holdings